OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
drug
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
OMRF researcher tests new approach for treating deadly blood infection
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Blood test identifies people at high risk for lupus
New research will help physicians better identify blood relatives of lupus patients at risk for developing the disease.
Celebrating 70 years of discoveries
Since 1946, OMRF has grown into an internationally recognized research institute.
